Alpha Teknova Inc (TKNO) 株価予測

Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 158 full-time employees. The company went IPO on 2021-06-25. The firm offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.